CD2AP
Basic information
Region (hg38): 6:47477789-47627263
Links
Phenotypes
GenCC
Source:
- focal segmental glomerulosclerosis 3, susceptibility to (Limited), mode of inheritance: AR
- familial idiopathic steroid-resistant nephrotic syndrome (Supportive), mode of inheritance: AD
- focal segmental glomerulosclerosis 3, susceptibility to (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Focal segmental glomerulosclerosis 3 | AR | Renal | The condition can involve renal failure, and early diagnosis may enable management considerations; Renal transplant has been described | Renal | 17713465 |
ClinVar
This is a list of variants' phenotypes submitted to
- Focal segmental glomerulosclerosis 3, susceptibility to (3 variants)
- Focal segmental glomerulosclerosis 3 (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD2AP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 31 | 35 | ||||
missense | 100 | 12 | 112 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 5 | 13 | 18 | |||
non coding | 66 | 44 | 57 | 167 | ||
Total | 4 | 4 | 174 | 88 | 58 |
Highest pathogenic variant AF is 0.0000264
Variants in CD2AP
This is a list of pathogenic ClinVar variants found in the CD2AP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-47477804-C-A | Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Jan 16, 2020) | ||
6-47477804-C-G | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Nov 11, 2018) | ||
6-47477807-C-T | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | ||
6-47477916-C-T | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | ||
6-47477921-G-C | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | ||
6-47477948-G-C | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | ||
6-47477978-G-A | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | ||
6-47478048-C-T | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | ||
6-47478053-A-C | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Nov 10, 2018) | ||
6-47478054-G-A | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | ||
6-47478075-TAGG-T | Focal segmental glomerulosclerosis | Likely benign (Jun 14, 2016) | ||
6-47478079-A-G | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Apr 27, 2017) | ||
6-47478115-C-G | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | ||
6-47478176-C-A | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | ||
6-47478191-T-A | Focal segmental glomerulosclerosis 3, susceptibility to • not specified | Benign (Jul 15, 2024) | ||
6-47478190-C-CAGG | Focal segmental glomerulosclerosis | Likely benign (Jun 14, 2016) | ||
6-47478236-G-GC | Focal segmental glomerulosclerosis | Uncertain significance (Jun 14, 2016) | ||
6-47478251-AAG-A | Likely benign (Aug 09, 2022) | |||
6-47478257-C-G | Likely benign (Nov 27, 2020) | |||
6-47478264-G-A | not specified | Benign/Likely benign (Jan 02, 2024) | ||
6-47478510-T-G | Benign (Nov 10, 2018) | |||
6-47503260-G-A | Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Jun 27, 2023) | ||
6-47503280-T-G | Uncertain significance (May 06, 2023) | |||
6-47503284-C-G | CD2AP-related disorder | Uncertain significance (Oct 11, 2023) | ||
6-47503298-A-G | Inborn genetic diseases | Uncertain significance (Oct 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD2AP | protein_coding | protein_coding | ENST00000359314 | 18 | 149475 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.230 | 0.770 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00215 | 323 | 323 | 1.00 | 0.0000155 | 4158 |
Missense in Polyphen | 63 | 82.35 | 0.76502 | 1105 | ||
Synonymous | -0.607 | 122 | 114 | 1.07 | 0.00000551 | 1212 |
Loss of Function | 4.36 | 9 | 38.0 | 0.237 | 0.00000202 | 483 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000446 | 0.000445 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis (PubMed:15800069). Plays a role in epithelial cell junctions formation (PubMed:22891260). {ECO:0000250|UniProtKB:F1LRS8, ECO:0000250|UniProtKB:Q9JLQ0, ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:22891260}.;
- Disease
- DISEASE: Focal segmental glomerulosclerosis 3 (FSGS3) [MIM:607832]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:12764198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Bacterial invasion of epithelial cells - Homo sapiens (human);Primary Focal Segmental Glomerulosclerosis FSGS;TCR;Nephrin family interactions;Cell-Cell communication;Nephrin/Neph1 signaling in the kidney podocyte;VEGFR1 specific signals
(Consensus)
Recessive Scores
- pRec
- 0.379
Intolerance Scores
- loftool
- 0.696
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.43
Haploinsufficiency Scores
- pHI
- 0.695
- hipred
- Y
- hipred_score
- 0.708
- ghis
- 0.656
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.894
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd2ap
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; immune system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- cd2ap
- Affected structure
- podocyte
- Phenotype tag
- abnormal
- Phenotype quality
- structure
Gene ontology
- Biological process
- substrate-dependent cell migration, cell extension;actin filament organization;cell cycle;signal transduction;vesicle organization;negative regulation of transforming growth factor beta1 production;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of receptor-mediated endocytosis;negative regulation of small GTPase mediated signal transduction;cell division;protein-containing complex assembly;cell-cell adhesion;positive regulation of protein localization to nucleus;regulation of actin cytoskeleton reorganization
- Cellular component
- ruffle;cytoplasm;plasma membrane;cell-cell junction;actin cytoskeleton;endocytic vesicle;filamentous actin;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- vascular endothelial growth factor receptor binding;structural constituent of cytoskeleton;protein binding;beta-catenin binding;protein C-terminus binding;SH3 domain binding;protein-containing complex binding;cadherin binding